Needle-exchange issue put on front burner. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.

Important note: Information in this article was accurate in 1997. The state of the art may have changed since the publication date.

Needle-exchange issue put on front burner. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.

AIDS Alert. 1997 Jul;12(7):79-80. Unique Identifier : AIDSLINE MED/97702686

Abstract: There are renewed pressures on the Federal government to lift the ban on needle exchange programs and to devote more funds to fighting what is the primary mode of HIV transmission in the United States. More than one-third of the 548,000 AIDS cases in the U.S. are attributed to injection drug use or sex with injection drug users, and health officials say that number is growing by 25,000 per year. Many studies show that needle exchange programs are effective, but Americans remain morally and politically opposed to them. Connecticut became the first State to legalize the purchase and possession of syringes five years ago, and has found that 75 percent of addicts report buying their syringes at a pharmacy instead of on the street.

Keywords: *HIV Infections/PREVENTION & CONTROL *Needle-Exchange Programs/LEGISLATION & JURISPRUD
971030
M97A1297

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1997. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1997. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .